论文部分内容阅读
探讨吲哚氰绿 15min潴留试验 (R15ICG)在原发性肝癌患者术前肝储备功能评估及其手术治疗中的临床价值 ;方法 :10 3例原发性肝癌患者术前作 (R15ICG检测及常规肝功能检查 ,比较其与手术后并发症发生率及肝功能恢复情况之间的关系 ;结果 :A组 (R15ICG<10 % )、B组 (R15ICG为 10 %～ 2 0 % )、C组 (R15ICG>2 0 % ) ,其术后肝功能不全发生率分别为 6 .89%、36 .1%和 70 .8% ,其差异有非常显著性意义 (P <0 .0 1) ;按术后肝功能恢复分为良好组、轻度组及重度组 ,各组之间Child -Pugh评分值及其它常规肝功能检查项目ALT、T -BIL及血清蛋白值差均亦无显著性意义 ;但各组间R15ICG值差异有显著性意义 (P <0 .0 5 ) ,其各组间值两两比较 ,其差异亦有显著性意义 (P <0 .0 5 ) ;结论 :R15ICG是肝癌病人切除术前的肝储备功能检测指标之一
To investigate the clinical value of the 15min retention of indocyanine green (R15ICG) test in patients with primary hepatic cancer before liver function assessment and surgical treatment;Methods: 103 patients with primary liver cancer before surgery (R15ICG test and routine Liver function tests were performed to compare the incidence of postoperative complications and recovery of liver function; results: Group A (R15ICG < 10%), Group B (R15ICG 10% to 20%), Group C ( R15ICG>20%), the incidence of postoperative hepatic insufficiency was 6.89%, 36.1% and 70.8%, respectively, and the difference was significant (P < 0.01); Post-hepatic function recovery was divided into good group, mild group and severe group. There was no significant difference in Child-Pugh scores and ALT, T-BIL and serum albumin values in other routine liver function tests. There was a significant difference in R15ICG values between the groups (P < 0.05), and the difference between the two groups was statistically significant (P <0.05). Conclusion: R15ICG is a liver cancer patient. One of the liver function tests before resection